Proteostasis Therapeutics, Inc.
(NASDAQ : PTI)

( )
PTI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.17%60.590.0%$1954.52m
REGNRegeneron Pharmaceuticals, Inc. -0.95%598.542.5%$1194.19m
GILDGilead Sciences, Inc. 4.22%77.541.0%$991.43m
AMGNAmgen, Inc. -0.05%220.881.3%$628.89m
NVAXNovavax, Inc. 0.93%44.66102.0%$620.64m
VRTXVertex Pharmaceuticals, Inc. -1.51%272.821.9%$540.62m
ILMNIllumina, Inc. 0.02%358.403.5%$384.32m
BIIBBiogen, Inc. -0.98%299.651.6%$368.00m
ALXNAlexion Pharmaceuticals, Inc. -0.08%113.682.0%$250.86m
SRNESorrento Therapeutics, Inc. -6.76%3.861.8%$246.90m
SGENSeattle Genetics, Inc. -2.98%150.436.1%$229.28m
AAgilent Technologies, Inc. 0.70%91.121.6%$215.04m
BMRNBioMarin Pharmaceutical, Inc. -3.33%107.514.3%$187.14m
MGNXMacroGenics, Inc. -2.52%20.486.2%$164.68m
INCYIncyte Corp. -5.09%93.802.5%$153.77m

Company Profile

Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.